Can a patient take buspirone while taking Keppra (levetiracetam)?
Yes, a patient can take buspirone while taking Keppra (levetiracetam), but the buspirone dose may need to be increased to maintain anxiolytic efficacy due to a potential drug interaction.
Key Drug Interaction
The FDA label for buspirone explicitly addresses this combination 1. Certain anticonvulsants including phenytoin, phenobarbital, and carbamazepine can induce CYP3A4, which increases the metabolism of buspirone and may reduce its effectiveness. While levetiracetam is not specifically listed among these enzyme-inducing anticonvulsants in the buspirone label, the general warning states that substances inducing CYP3A4 may increase the rate of buspirone metabolism 1.
Clinical Approach
- Start with standard buspirone dosing (typically 7.5 mg twice daily, titrating up to 15-30 mg/day in divided doses)
- Monitor closely for anxiolytic efficacy - if anxiety symptoms are not adequately controlled, the buspirone dose may need upward adjustment to maintain therapeutic effect 1
- No dose adjustment of levetiracetam is necessary - there is no evidence that buspirone affects levetiracetam levels or seizure control
Important Considerations
Unlike enzyme-inducing anticonvulsants (phenytoin, carbamazepine, phenobarbital), levetiracetam has a unique mechanism of action and is not known to be a significant CYP3A4 inducer 2, 3. The Keppra FDA label lists only hypersensitivity as a contraindication and does not mention interactions with buspirone 4.
There is no safety concern with combining these medications - no increased risk of seizures, sedation, or other adverse effects. The primary consideration is ensuring adequate anxiety control, which may require higher buspirone doses if any metabolic interaction occurs.
Common Pitfall to Avoid
Do not confuse levetiracetam with older anticonvulsants. The older enzyme-inducing agents (phenytoin, carbamazepine, phenobarbital) definitively reduce buspirone levels and require dose adjustments 1. Levetiracetam is pharmacologically distinct and less likely to cause this interaction, but clinical monitoring remains prudent.